Lymphocyte to C-Reactive Protein Ratio as an Early Biomarker to Distinguish Sepsis from Pneumonia in Neonates

Xinrui Liu,Yuan Mu
DOI: https://doi.org/10.2147/JIR.S424897
IF: 4.5
2023-08-18
Journal of Inflammation Research
Abstract:Xinrui Liu, 1 Yuan Mu 2 1 Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, People's Republic of China; 2 Institute of Thermology, Henan Institute of Metrology and Testing Sciences, Zhengzhou, People's Republic of China Correspondence: Xinrui Liu, Email Background: Neonatal sepsis is an acute and severe disease that seriously threatens the life and health of newborns. Neonates with pneumonia may also have unrecognized neonatal sepsis. Early diagnosis of neonatal sepsis is beneficial for early treatment. This study aimed to evaluate the clinical significance of the lymphocyte-to-C-reactive protein ratio (LCR) as an early biomarker to distinguish sepsis from pneumonia. Methods: This retrospective study enrolled 1635 neonates with pneumonia from February 2016 to March 2022. Among them, 182 cases were diagnosed with sepsis based on the positive blood culture results. Clinical and laboratory data were extracted from the electronic medical records. LCR was calculated as the ratio of the total lymphocyte count (× 10 9 cells/L) to the C-reactive protein level (mg/L). Binary logistic regression analysis was conducted to evaluate the clinical significance of LCR as an early biomarker in distinguishing sepsis from pneumonia. Receiver operating characteristic (ROC) analysis was performed to assess the diagnostic value of LPCR in sepsis cases. All statistical analyses were conducted using Statistical Product and Service Solutions, version 24.0. Results: The neonates with pneumonia combined with sepsis had a lower LCR than that of the neonates with pneumonia. Further analysis showed that the prevalence of neonatal pneumonia combined with sepsis was significantly higher in the low-LCR group than in the high-LCR group (20.7% vs 5.5%, P < 001). Binary logistic regression revealed that LCR was an independent risk factor for identifying pneumonia combined with sepsis. The ROC curve analysis revealed that LCR had better power than the lymphocyte count and CRP level individually in diagnosing neonatal pneumonia combined with sepsis (0.72 vs 0.65 vs 0.66, P < 0.001), with 62% sensitivity and 72% specificity. Conclusion: LCR can be a potential early biomarker in distinguishing neonates with sepsis from those with pneumonia. Keywords: lymphocyte to C-reactive protein ratio, neonates, pneumonia, sepsis Neonates are susceptible to pathogenic microorganisms and may develop into neonatal pneumonia or sepsis owing to their immature immune systems. 1 Neonatal sepsis is a severe threat to the life and health of newborns, affecting 2/1000 live births, with a high mortality rate ranging from 11% to 19%. 2 Furthermore, neonates with pneumonia may also have unrecognized neonatal sepsis. In some cases, neonates have both pneumonia and sepsis, and they are not treated according to the intervention guidelines for sepsis. Hence, these neonates cannot benefit from the early treatment of sepsis, as encouraged by the Surviving Sepsis Campaign Physician's management guidelines. 3 However, there are many difficulties and uncertainties in the early diagnosis of neonatal sepsis, such as non-specific clinical symptoms and lower rates of positive blood culture results. Therefore, exploring more convenient and accurate indicators for the early detection of neonatal sepsis is critical. Neonatal sepsis is characterized by systemic inflammatory response syndrome, 4 indicating that inflammatory markers may be clinically relevant in identifying neonatal sepsis. Lymphocytes are the primary white blood cells that help the body fight infection and disease. 5,6 In sepsis, various cytokines can induce apoptosis of the lymphocytes. 7,8 Several studies have reported that lymphocytopenia is frequently observed in patients with sepsis, and persistent lymphocytopenia is associated with high mortality rates. 9–13 C-reactive protein (CRP) is a protein produced by the liver and increases significantly when there is inflammation in the body. 14 CRP is one of the most investigated and widely used laboratory parameters to evaluate the body's inflammation status. 15 Multiple studies have confirmed that CRP has high clinical significance in the early diagnosis of sepsis and is an important predictor and risk factor for poor outcomes in neonates with sepsis. 16,17 The lymphocyte-to-CRP ratio (LCR) is an index calculated as the ratio of the total lymphocyte count (×10 9 cells/L) to the CRP level (mg/L). Studies have reported that LCR decreases in patients with infectious diseases and is a helpfu -Abstract Truncated-
immunology
What problem does this paper attempt to address?